110 related articles for article (PubMed ID: 20433950)
21. [Kaposi sarcoma: a virus-induced tumor?].
Thimme R; Blum HE; Weber F
Dtsch Med Wochenschr; 1997 Oct; 122(43):1323-6. PubMed ID: 9410697
[No Abstract] [Full Text] [Related]
22. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.
Foreman KE; Friborg J; Kong WP; Woffendin C; Polverini PJ; Nickoloff BJ; Nabel GJ
N Engl J Med; 1997 Jan; 336(3):163-71. PubMed ID: 8988896
[TBL] [Abstract][Full Text] [Related]
23. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
[No Abstract] [Full Text] [Related]
24. Correlation between enzyme-linked immunosorbent assay and immunofluorescence assay with lytic antigens for detection of antibodies to human herpesvirus 8.
Topino S; Vincenzi L; Mezzaroma I; Nicastri E; Andreoni M; Sirianni MC
Clin Diagn Lab Immunol; 2001 Jan; 8(1):203-5. PubMed ID: 11139222
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.
Cottoni F; Uccini S
Science; 1997 Dec; 278(5345):1972; author reply 1972-3. PubMed ID: 9417646
[No Abstract] [Full Text] [Related]
26. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection.
Oksenhendler E; Cazals-Hatem D; Schulz TF; Barateau V; Grollet L; Sheldon J; Clauvel JP; Sigaux F; Agbalika F
N Engl J Med; 1998 May; 338(22):1585-90. PubMed ID: 9603796
[No Abstract] [Full Text] [Related]
27. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
28. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
29. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
[TBL] [Abstract][Full Text] [Related]
30. [Protocol for inducing infliximab tolerance in a patient with psoriatic spondylarthritis].
Gallardo R; Fobelo MJ; Pastor C; Orta-Cuevas JC
Farm Hosp; 2010; 34(2):94-6. PubMed ID: 20304368
[No Abstract] [Full Text] [Related]
31. Optic neuritis in a psoriatic arthritis patient treated by infliximab.
Minami-Hori M; Tsuji H; Takahashi H; Hanada K; Iizuka H
J Dermatol; 2013 Apr; 40(4):298-9. PubMed ID: 23289758
[No Abstract] [Full Text] [Related]
32. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
34. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.
Ueno T; Mitsuishi T; Kimura Y; Kato T; Hasegawa H; Katano H; Sata T; Kurane S; Kawana S
Eur J Dermatol; 2007; 17(6):539-40. PubMed ID: 17951139
[No Abstract] [Full Text] [Related]
35. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
[No Abstract] [Full Text] [Related]
36. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis.
Cañete JD; Pablos JL; Sanmartí R; Mallofré C; Marsal S; Maymó J; Gratacós J; Mezquita J; Mezquita C; Cid MC
Arthritis Rheum; 2004 May; 50(5):1636-41. PubMed ID: 15146434
[TBL] [Abstract][Full Text] [Related]
37. [Kaposi sarcoma associated with infliximab treatment].
Martínez-Martínez ML; Pérez-García LJ; Escario-Travesedo E; Ribera-Vaquerizo PA
Actas Dermosifiliogr; 2010 Jun; 101(5):462-4. PubMed ID: 20525496
[No Abstract] [Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
39. Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.
Cisternas M; Gutiérrez M; Jacobelli S
Arthritis Rheum; 2002 Nov; 46(11):3107-8; author reply 3108-9. PubMed ID: 12428265
[No Abstract] [Full Text] [Related]
40. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
